Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy

Supportive Care in Cancer

Volumn 23, Issue 4, 2015, Pages 943-951

  Pachman, Deirdre R ^a   Weisbrod, Breanna L ^a   Seisler, Drew K ^a   Barton, Debra L ^b   Fee Schroeder, Kelliann C ^a   Smith, Thomas J ^c   Lachance, Daniel H ^a   Liu, Heshan ^a   Shelerud, Randy A ^a   Cheville, Andrea L ^a   Loprinzi, Charles L ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chemotherapy induced peripheral neuropathy; Electroanalgesia; Scrambler therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CLINICAL ARTICLE; COLORECTAL CANCER; ELECTROSTIMULATION THERAPY; FEMALE; HAND FOOT SYNDROME; HUMAN; LOW BACK PAIN; LYMPHOMA; MALE; OVARY CANCER; PAIN ASSESSMENT; PARESTHESIA; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RYDEL SEIFFER GRADUATED TUNING FORK; SCRAMBLER THERAPY; SKIN TINGLING; TUNING FORK; VIBRATION SENSE; CHEMICALLY INDUCED; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROTHERAPY; MIDDLE AGED; NEOPLASMS; PERIPHERAL NERVOUS SYSTEM DISEASES; PILOT STUDY; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PERIPHERAL NERVOUS SYSTEM DISEASES; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84942123176     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2424-8     Document Type: Article

References (25)

1. Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden JD 3rd, Kugler JW, Hoff KL, Reddy PS, Rowland KM Jr, Riepl M, Christensen B, Loprinzi CL (2011) A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer 19:833–841
2. Campbell TC, Nimunkar AJ, Retseck J, Eickhoff JC, Backonja M, Cleary JF, Kwekkeboom KL, Yen TY (2013) A randomized, double-blind study of "Scrambler" therapy versus sham for painful chemotherapy-induced peripheral neuropathy (CIPN). J Clin Oncol 31: suppl; abstr 9635
3. Coyne PJ, Wan W, Dodson P, Swainey C, Smith TJ (2013) A trial of scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother 27:359–364
4. de Boer AG, van Lanschot JJ, Stalmeier PF, van Sandick JW, Hulscher JB, de Haes JC, Sprangers MA (2004) Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res 13:311–320
5. Durand JP, Deplanque G, Montheil V, Gornet JM, Scotte F, Mir O, Cessot A, Coriat R, Raymond E, Mitry E, Herait P, Yataghene Y, Goldwasser F (2011) Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 1:200–5
6. Eurich DT, Johnson JA, Reid KJ, Spertus JA (2006) Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes 4:89
7. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A (1993) Transition questions to assess outcomes in rheumatoid arthritis. Br J Rheumatol 32:807–811
8. Hammack JE, Michalak JC, Loprinzi CL, Sloan JA, Novotny PJ, Soori GS, Tirona MT, Rowland KM Jr, Stella PJ, Johnson JA (2002) Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 98:195–203
9. Hauser K, Walsh D (2008) Visual analogue scales and assessment of quality of life in cancer. J Support Oncol 6:277–282
10. Kastenbauer T, Sauseng S, Brath H, Abrahamian H, Irsigler K (2004) The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer. Diabetic Med: J B Diabetic Assoc 21:563–567
11. Kautio AL, Haanpaa M, Saarto T, Kalso E (2008) Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manag 35:31–39
12. Locke DE, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, Rummans TA, Ballman KV, Schaefer PL, Buckner JC (2007) Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manag 34:628–638
13. Marineo G (2003) Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP 4:1–10
14. Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ (2011) Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized. Controll Trial J Pain Symptom Manag 43(1):87–95
15. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL (2008) Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 112:2802–2808
16. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA, Wong GY (2007) Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 110:2110–2118
17. Ricci M, Pirotti S, Scarpi E, Burgio M, Maltoni M, Sansoni E, Amadori D (2011) Managing chronic pain: results from an open-label study using MC5-A Calmare(R) device Support Care Cancer. (2):405–12
18. Sabato AF, Marineo G, Gatti A (2005) Scrambler therapy. Minerva Anestesiol 71:479–482
19. Saif MW, Syrigos K, Kaley K, Isufi I (2010) Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy. Anticancer Res 30:2927–2933
20. Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindqwister N, Gilman PB, Shapiro CL (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial Jama 309: 1359–1367
21. Smith TJ, Coyne PJ, Parker GL, Dodson P, Ramakrishnan V (2010) Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare(R)) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manag 40:883–891
22. Sparadeo F, Kaufman C, D'Amato S (2012) Scrambler therapy: an innovative and effective treatment for chronic neuropathic pain. J Life Care Plan 11:3–15
23. Whitton TL, Johnson RW, Lovell AT (2005) Use of the Rydel-Seiffer graduated tuning fork in the assessment of vibration threshold in postherpetic neuralgia patients and healthy controls. Eur J Pain 9:167–171
24. Windebank AJ, Grisold W (2008) Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13:27–46
25. Wolf SL, Barton DL, Qin R, Wos EJ, Sloan JA, Liu H, Aaronson NK, Satele DV, Mattar BI, Green NB, Loprinzi CL (2011) The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer 20(3):625–32